Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paper
Top Cited Papers
Open Access
- 1 June 2020
- Vol. 75 (6), 1300-1315
- https://doi.org/10.1111/all.14122
Abstract
A recent survey of the European Academy of Allergy and Clinical Immunology (EAACI) Drug Allergy Interest Group (DAIG) on how European allergy specialists deal with beta-lactam (BL) hypersensitivity demonstrated a significant heterogeneity in current practice, suggesting the need to review and update existing EAACI guidelines in order to make the diagnostic procedures as safe and accurate, but also as cost-effective, as possible. For this purpose, a bibliographic search on large studies regarding BL hypersensitivity diagnosis was performed by an EAACI task force, which reviewed and evaluated the literature data using the GRADE system for quality of evidence and strength of recommendation. The updated guidelines provide a risk stratification in BL hypersensitivity according to index reaction(s), as well as an algorithmic approach, based on cross-reactivity studies, in patients with a suspicion of BL hypersensitivity and an immediate need for antibiotic therapy, when referral to an allergist is not feasible. Furthermore, the update addresses availability and concentrations of skin test (ST) reagents, ST and drug provocation test (DPT) protocols, and diagnostic algorithms and administration of alternative BL in allergic subjects. Specifically, distinct diagnostic algorithms are suggested depending on risk stratification of the patient into high and low risk based on the morphology and chronology of the reaction, immediate (ie, occurring within 1-6 hours after the last administered dose) or nonimmediate (ie, occurring more than 1 hour after the initial drug administration), and the reaction severity. Regarding the allergy workup, the main novelty of this document is the fact that in some low-risk nonimmediate reactions ST are not mandatory, especially in children. For DPT, further studies are necessary to provide data supporting the standardization of protocols, especially of those regarding nonimmediate reactions, for which there is currently no consensus.This publication has 135 references indexed in Scilit:
- Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challengeAllergy, 2013
- One-week Oral Challenge with Penicillin in Diagnosis of Penicillin AllergyActa Dermato-Venereologica, 2012
- European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009)Journal of Antimicrobial Chemotherapy, 2011
- European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997-2009)Journal of Antimicrobial Chemotherapy, 2011
- Results of drug hypersensitivity evaluations in a large group of children and adultsClinical & Experimental Allergy, 2011
- The in vitro diagnosis of drug allergy: status and perspectivesAllergy, 2011
- The very limited usefulness of skin testing with penicilloyl‐polylysine and the minor determinant mixture in evaluating nonimmediate reactions to penicillinsAllergy, 2010
- Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillinJournal of Antimicrobial Chemotherapy, 2007
- Allergy to betalactam antibiotics in children: a prospective follow-up study in retreated children after negative responses in skin and challenge testsAllergy, 2007
- Immediate allergic reactions to cephalosporins: Evaluation of cross-reactivity with a panel of penicillins and cephalosporinsJournal of Allergy and Clinical Immunology, 2006